Advent International believes that Indian valuations are not a barrier to making deals, as they are relative to growth opportunities and ri...

Jayesh Visaria, who's head of healthcare & consumer at I Banking at Barclays, quit the global Bank after a stint of 8 years. Along with an ...

From vanilla debt products to complex, new structures, storied UK bank takes new issuers, co-led around $5 billion on loans for PEs in last...

Advent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) b...

Market capitalisation of Suven Pharma, as on Friday, was ₹12,682.43 crore. ET was the first to report on the sale on December 23. Advent is...

Announcement expected as early as Monday morning. Open offer if fully subscribed to could make it a $1 bn deal

Promoters Venkateswarlu Jasti and his family split Suven Life Sciences in FY20, turning the CRAMS business into a separately listed company...

Once done, this would be the second largest hospital buyout in India after the IHH-Fortis transaction in 2018. This transaction will also g...

The over 1 per cent rise in Reliance Industries’ stake was one of the major reasons both the Nifty 50 and Sensex ended the session in the g...

Investors kept their powder dry, awaiting IIP & retail inflation prints due later in the day.

Reliance Industries said on Wednesday that the merger of Reliance Petroleum with itself has been approved by its shareholders and creditors.

The high-profile Mylan-Matrix deal is likely to trigger a series of mergers and acquisitions (M&A) in the Indian pharmaceutical market. Aro...